Replies to post #174530 on Biotech Values

[DewDiligence]

Teva dropping Phase III laquinimod trial, Libretto.

Even though Teva/Active are continuing to run two other Laquinimod trials, I presume from your prior posts on this subject that you (as I do) ascribe little or no value to the Laquinimod program.